Literature DB >> 20724506

Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture.

D M O'Sullivan1, T D McHugh1, S H Gillespie2,1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20724506     DOI： 10.1099/jmm.0.019091-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  17 in total

Review 1.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

2.  Mechanisms for defining supercoiling set point of DNA gyrase orthologs: II. The shape of the GyrA subunit C-terminal domain (CTD) is not a sole determinant for controlling supercoiling efficiency.

Authors:  Elsa M Tretter; James M Berger
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

Review 3.  Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'.

Authors:  D W Dowdy; C Dye; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-07       Impact factor: 2.373

Review 4.  Isoniazid-resistant tuberculosis: a cause for concern?

Authors:  H R Stagg; M C Lipman; T D McHugh; H E Jenkins
Journal:  Int J Tuberc Lung Dis       Date:  2017-02-01       Impact factor: 2.373

5.  A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.

Authors:  Kamunkhwala Gausi; Elisa H Ignatius; Xin Sun; Soyeon Kim; Laura Moran; Lubbe Wiesner; Florian von Groote-Bidlingmaier; Richard Hafner; Kathleen Donahue; Naadira Vanker; Susan L Rosenkranz; Susan Swindells; Andreas H Diacon; Eric L Nuermberger; Kelly E Dooley; Paolo Denti
Journal:  Am J Respir Crit Care Med       Date:  2021-12-01       Impact factor: 21.405

Review 6.  Resistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) Antibiotics.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

7.  A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.

Authors:  Emmanuel Chigutsa; Kashyap Patel; Paolo Denti; Marianne Visser; Gary Maartens; Carl M J Kirkpatrick; Helen McIlleron; Mats O Karlsson
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

8.  Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity.

Authors:  Solomon P le Roux; Caryn Upton; Naadira Vanker; Kelly E Dooley; Andreas H Diacon
Journal:  Am J Respir Crit Care Med       Date:  2021-03-01       Impact factor: 21.405

9.  HIV infection and geographically bound transmission of drug-resistant tuberculosis, Argentina.

Authors:  Viviana Ritacco; Beatriz López; Marta Ambroggi; Domingo Palmero; Bernardo Salvadores; Elida Gravina; Eduardo Mazzeo; Susana Imaz; Lucía Barrera
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

10.  Dominant incidence of multidrug and extensively drug-resistant specific Mycobacterium tuberculosis clones in Osaka Prefecture, Japan.

Authors:  Aki Tamaru; Chie Nakajima; Takayuki Wada; Yajun Wang; Manabu Inoue; Ryuji Kawahara; Ryoji Maekura; Yuriko Ozeki; Hisashi Ogura; Kazuo Kobayashi; Yasuhiko Suzuki; Sohkichi Matsumoto
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.